ZUKANORM D 10

About

Zukanorm D 10 is a combination medication designed for the effective management of type 2 diabetes mellitus. It typically combines Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, with Metformin, a biguanide. Vildagliptin works by inhibiting the DPP-4 enzyme, which leads to increased levels of active incretin hormones (GLP-1 and GIP). These hormones enhance glucose-dependent insulin secretion from pancreatic beta cells and suppress glucagon secretion from alpha cells, thereby improving both fasting and postprandial glucose levels. Metformin complements this action by primarily reducing hepatic glucose production, decreasing intestinal glucose absorption, and improving insulin sensitivity in peripheral tissues. This dual mechanism addresses multiple aspects of glucose dysregulation in type 2 diabetes, providing comprehensive glycemic control. It is often prescribed when diet and exercise, or monotherapy with either component, are insufficient to achieve target blood sugar levels, offering a robust therapeutic option for patients.

Uses

• Management of type 2 diabetes mellitus.
• Improvement of glycemic control in adults.
• Used as an adjunct to diet and exercise.
• When monotherapy is inadequate.

Directions For Use

Take this medication orally as directed by your physician, usually with meals to minimize gastrointestinal side effects. Do not crush or chew the tablet.

Benefits

• Provides dual-action glycemic control.
• Lowers both fasting and post-meal blood sugar.
• Improves insulin sensitivity.
• Reduces hepatic glucose production.
• Generally well-tolerated.
• Convenient fixed-dose combination.

Side Effects

• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Headache
• Upper respiratory tract infection
• Nasopharyngitis
• Hypoglycemia (especially with other antidiabetics)
• Lactic acidosis (rare, but serious with Metformin)
• Vitamin B12 deficiency (long-term Metformin use)
• Dizziness
• Fatigue

Safety Measures

• Alcohol - Avoid excessive alcohol consumption as it can increase the risk of lactic acidosis, a rare but serious side effect, especially when taking Metformin.
• Pregnancy - Consult your doctor. This medication is generally not recommended during pregnancy unless clearly necessary, as its safety has not been fully established.
• Breastfeeding - Consult your doctor. Components of this medication may pass into breast milk, and its use during breastfeeding should be carefully considered.
• Liver - Use with caution in patients with liver impairment. Metformin is contraindicated in severe hepatic dysfunction due to increased risk of lactic acidosis.
• Kidney - Use with caution and dose adjustment in patients with kidney impairment. Metformin is contraindicated in severe renal impairment due to accumulation and increased risk of lactic acidosis.
• Lung - Use with caution in patients with severe lung conditions, as these may predispose to lactic acidosis.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.